
Source: Mars
Mars, Incorporated plans to invest an estimated $1.4 billion in its U.S. manufacturing and operations in 2027, according to a Nov. 10 company announcement. That’s the most Mars has invested in a single year.
The money builds on more than $9 billion Mars has invested in U.S. manufacturing and operations since 2017. According to CFO Claus Aagaard, 94% of the Mars products sold in the U.S. are made here.
Four Hospitals, Funded and Located
The only part of the 2027 plan Mars spelled out is four Mars Veterinary Health hospitals opening early next year. They’re backed by more than $34 million:
Three BluePearl Pet Hospitals in Ellicott City, MD, and Austin and Katy, TX
One Banfield Pet Hospital in Wilmington, NC
That averages out to more than $8.5 million per hospital, and the four sites will unlock up to 195 new jobs. The release doesn’t say where the rest of the $1.4 billion will go.
Money Already in Motion
Mars also pointed to recent 2026 investments:
Salt Lake City, UT: $60 million for two Trü Frü lines inside a $240 million factory that opened last year. The site will have capacity for 17 million Trü Frü frozen products a year.
Waco, TX: $165 million since 2024, with recent projects heavily focused on energy efficiency and operational excellence. The plant marks 50 years this month.
Columbus, OH: $49 million to bring TEMPTATIONS Lickable Treats production to the U.S. Mars has invested $162 million in the site since 2022.
A Long List of Buildings
Mars runs more than 60 U.S. factories, research labs, and offices, plus over 2,000 vet clinics and hospitals. It added 15 facilities in the last year through its Kellanova acquisition.
The company says it will keep investing to modernize its full U.S. portfolio. So far, more than $34 million of the record $1.4 billion has a destination, and the rest hasn’t been detailed.

